Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fautrel

Showing results (81-90 of 370) with videos related to

Pageof 37
Sort By:
RMD Open|June 3, 2016
Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort dataBenjamin Granger, Bernard Combe, Xavier Le Loet, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 27, 2008
Efficacy of anakinra in a case of refractory Still diseaseSeverine Debiais, Francois Maillot, Luminita Luca, et al.
Arthritis Research & Therapy|November 21, 2012
Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohortBruno Fautrel, Benjamin Granger, Bernard Combe, et al.
Joint Bone Spine|December 17, 2015
Healthcare service utilisation costs attributable to rheumatoid arthritis in France: Analysis of a representative national claims databaseBruno Fautrel, Gabrielle Cukierman, Jean-Michel Joubert, et al.
RMD Open|November 5, 2020
Steps in implementing a health economic evaluationFrancis Guillemin, Maarten de Wit, Bruno Fautrel, et al.
RMD Open|November 5, 2020
Health technology assessment: a frameworkManuela Joore, Sabine Grimm, Annelies Boonen, et al.
Arthritis Care & Research|February 23, 2012
Factors associated with fatigue in early arthritis: results from a multicenter national French cohort studyAnne-Christine Rat, Jacques Pouchot, Bruno Fautrel, et al.
Arthritis Care & Research|July 10, 2013
Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohortVeronique Vesperini, Cedric Lukas, Bruno Fautrel, et al.
Joint Bone Spine|December 19, 2015
Characteristics and management of rheumatoid arthritis in France: Analysis of a representative French national claims database resulting in an estimated prevalence of 0.35Bruno Fautrel, Gabrielle Cukierman, Jean-Michel Joubert, et al.
RMD Open|November 5, 2020
Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?Maarten de Wit, Francis Guillemin, Sabine Grimm, et al.
Pageof 37

Showing results (81-90 of 370) with videos related to

Sort By:
Pageof 37
RMD Open|June 3, 2016
Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort dataBenjamin Granger, Bernard Combe, Xavier Le Loet, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 27, 2008
Efficacy of anakinra in a case of refractory Still diseaseSeverine Debiais, Francois Maillot, Luminita Luca, et al.
Arthritis Research & Therapy|November 21, 2012
Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohortBruno Fautrel, Benjamin Granger, Bernard Combe, et al.
Joint Bone Spine|December 17, 2015
Healthcare service utilisation costs attributable to rheumatoid arthritis in France: Analysis of a representative national claims databaseBruno Fautrel, Gabrielle Cukierman, Jean-Michel Joubert, et al.
RMD Open|November 5, 2020
Steps in implementing a health economic evaluationFrancis Guillemin, Maarten de Wit, Bruno Fautrel, et al.
RMD Open|November 5, 2020
Health technology assessment: a frameworkManuela Joore, Sabine Grimm, Annelies Boonen, et al.
Arthritis Care & Research|February 23, 2012
Factors associated with fatigue in early arthritis: results from a multicenter national French cohort studyAnne-Christine Rat, Jacques Pouchot, Bruno Fautrel, et al.
Arthritis Care & Research|July 10, 2013
Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohortVeronique Vesperini, Cedric Lukas, Bruno Fautrel, et al.
Joint Bone Spine|December 19, 2015
Characteristics and management of rheumatoid arthritis in France: Analysis of a representative French national claims database resulting in an estimated prevalence of 0.35Bruno Fautrel, Gabrielle Cukierman, Jean-Michel Joubert, et al.
RMD Open|November 5, 2020
Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?Maarten de Wit, Francis Guillemin, Sabine Grimm, et al.
Pageof 37